Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:1462-1468

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenzel, V.
Right arrow Articles by Koehler, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel, V.
Right arrow Articles by Koehler, R. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*CPR
Hazardous Substances DB
*EPINEPHRINE
*VASOPRESSIN

(Stroke. 1998;29:1462-1468.)
© 1998 American Heart Association, Inc.


Original Contributions

Vasopressin Combined With Epinephrine Decreases Cerebral Perfusion Compared With Vasopressin Alone During Cardiopulmonary Resuscitation in Pigs

Volker Wenzel, MD; Karl H. Lindner, MD; Sven Augenstein; Andreas W. Prengel, MD; Hans U. Strohmenger, MD

From the Department of Anesthesiology, University of Ulm, Ulm, Germany (V.W., K.H.L., S.A., A.W.P., H.U.S.); the Department of Anaesthesia and Intensive Care Medicine, Leopold Franzens University of Innsbruck, Austria (V.W., K.H.L., S.A., H.U.S.); and the Department of Anesthesiology, Knappschaft Hospital, Ruhr University, Bochum, Germany (A.W.P.).

Correspondence to Dr Volker Wenzel, The Leopold Franzens University of Innsbruck, Department of Anaesthesia and Intensive Care Medicine, Anichstrasse 35, 6020 Innsbruck, Austria. E-mail Volker.Wenzel{at}uibk.ac.at

Background and Purpose—It is unknown whether a combination of vasopressin and epinephrine may be superior to vasopressin alone by targeting both nonadrenergic and adrenergic receptors.

Methods—After 15 minutes of cardiac arrest (13 minutes of ventricular fibrillation and 2 minutes of pulseless electrical activity) and 3 minutes of chest compressions, 16 animals were randomly treated with either 0.8 U/kg vasopressin (n=8) or 0.8 U/kg vasopressin combined with 200 µg/kg epinephrine (n=8).

Results—Comparison of vasopressin with vasopressin and epinephrine at 90 seconds and 5 minutes after drug administration resulted in comparable mean (±SEM) coronary perfusion pressure (54±3 versus 57±5 and 36±4 versus 35±4 mm Hg, respectively), cerebral perfusion pressure (59±6 versus 65±8 and 40±6 versus 39±6 mm Hg, respectively), and median (25th to 75th percentiles) left ventricular myocardial blood flow [116 (81 to 143) versus 108 (97 to 125) and 44 (35 to 81) versus 62 (42 to 74) mL · min-1 · 100 g-1, respectively], but significantly increased (P<0.05) total cerebral blood flow [81 (77 to 95) versus 39 (34 to 58) and 50 (43 to 52) versus 28 (16 to 35) mL · min-1 · 100 g-1, respectively]. Return of spontaneous circulation rates in both groups were comparable (vasopressin, 7 of 8; vasopressin and epinephrine, 6 of 8).

Conclusions—Comparison of vasopressin with vasopressin and epinephrine resulted in comparable left ventricular myocardial blood flow but significantly increased cerebral perfusion.

Editorial Comment

Raymond C. Koehler, PhD, Guest Editor

Department of Anesthesiology/Critical Care Medicine The Johns Hopkins University Baltimore, Maryland




This article has been cited by other articles:


Home page
CirculationHome page
V. D. Mayr, V. Wenzel, W. G. Voelckel, A. C. Krismer, T. Mueller, K. G. Lurie, and K. H. Lindner
Developing a Vasopressor Combination in a Pig Model of Adult Asphyxial Cardiac Arrest
Circulation, October 2, 2001; 104(14): 1651 - 1656.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
R. V. DiGregorio
Pharmacotherapeutic Advances in Cardiac Resuscitation: A Review of the Advanced Cardiac Life Support (ACLS) 2000 Guidelines and Their Impact on Pharmacy Practice
Journal of Pharmacy Practice, February 1, 2001; 14(1): 41 - 53.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
U. Achleitner, V. Wenzel, H.-U. Strohmenger, A. C. Krismer, K. G. Lurie, K. H. Lindner, and A. Amann
The Effects of Repeated Doses of Vasopressin or Epinephrine on Ventricular Fibrillation in a Porcine Model of Prolonged Cardiopulmonary Resuscitation
Anesth. Analg., May 1, 2000; 90(5): 1067 - 1075.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. A. Ewy and J. P. Ornato
Emergency cardiac care: introduction
J. Am. Coll. Cardiol., March 15, 2000; 35(4): 825 - 880.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Wenzel, K. H. Lindner, A. C. Krismer, W. G. Voelckel, M. F. Schocke, W. Hund, M. Witkiewicz, E. A. Miller, G.u. Klima, J.o. Wissel, et al.
Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 527 - 533.
[Abstract] [Full Text] [PDF]